进行性核上性麻痹患者自报快速眼动睡眠行为障碍:临床与18F-Florzolotau PET影像学发现
该研究连续纳入2019年5月至2022年3月中国一家三级医院符合2017年运动障碍学会临床标准的进行性核上性麻痹(PSP)患者148例,采用RBD单问题筛查自报快速眼动睡眠行为障碍(RBD),并行18F-florzolotau PET成像。18.2%(27/148)患者存在自报RBD,其PSP评定量表评分更高(38.0 vs 27.0,效应量=0.256,p=0.002),蓝斑18F-florzolotau结合显著更高(1.50 vs 1.38,效应量=0.231,p=0.003),RBD频率与蓝斑tau病理相关(n=8,r=0.752,p=0.002)。
要点
- 148例PSP患者中18.2%(27/148)存在自报RBD。
- 自报RBD患者PSP评定量表评分更高(38.0 vs 27.0,p=0.002)。
- 自报RBD患者蓝斑18F-florzolotau结合更高(1.50 vs 1.38,p=0.003)。
核心结论
- 约五分之一的PSP患者报告RBD,并表现出更严重的运动和非运动症状。
- 蓝斑18F-florzolotau结合升高及其与RBD症状存在的关联,凸显tau病理在破坏睡眠调节神经环路中的关键作用。
研究设计与样本
- 连续纳入2019年5月至2022年3月中国一家三级医院符合2017年运动障碍学会临床标准的PSP患者148例。
- 患者接受全面临床评估和18F-florzolotau PET成像以探究tau沉积模式。
- 采用RBD单问题筛查识别自报RBD,并从病史中回顾性收集其频率。
主要发现
- 18.2%(27/148)的参与者存在自报RBD。
- PSP-Richardson综合征和PSP-帕金森综合征患者自报RBD频率最高(分别为21.7%和18.5%),PSP-进行性步态冻结为9.7%。
- 自报RBD患者与无自报RBD患者年龄和性别相似,但前者PSP评定量表评分更高(38.0 vs 27.0,效应量=0.256,p=0.002)。
- 自报RBD患者蓝斑18F-florzolotau结合显著更高(1.50 vs 1.38,效应量=0.231,p=0.003),错误发现率校正后仍显著(p=0.042)。
- RBD频率与蓝斑tau病理相关(n=8,r=0.752,p=0.002)。
局限性
- 未来需要更大样本量的研究,在自报RBD的PSP患者中纳入多导睡眠监测,以进一步阐明这一关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Rapid eye movement sleep behavior disorder (RBD) is increasingly recognized in patients with tauopathies, but its significance and underpinnings remain unclear. To address this gap, we investigated the prevalence of self-reported RBD in patients with progressive supranuclear palsy (PSP) and explored its clinical and imaging correlates using 18F-florzolotau PET imaging. METHODS: We consecutively enrolled patients meeting the 2017 Movement Disorder Society clinical criteria for PSP at a Chinese tertiary hospital between May 2019 and March 2022. Patients underwent comprehensive clinical assessments and 18F-florzolotau PET to investigate tau deposition patterns. The presence of self-reported RBD was identified using the RBD Single-Question Screen, while its frequency was retrospectively collected from medical history. RESULTS: We examined 148 patients recruited in the ongoing Progressive Supranuclear Palsy Neuroimage Initiative cohort. Self-reported RBD was identified in 18.2% of the participants (27/148). Patients with PSP-Richardson syndrome and PSP-parkinsonism reported the highest frequencies of self-reported RBD (21.7% and 18.5%, respectively), compared with PSP-progressive gait freezing (9.7%). While age and sex were similar in patients with and without self-reported RBD, the former group exhibited greater disease severity, as indicated by higher PSP Rating Scale (PSPrs) scores (38.0 vs 27.0, effect size = 0.256, p = 0.002). Furthermore, patients with RBD had significantly higher 18F-florzolotau binding in the locus coeruleus (LC) (1.50 vs 1.38, effect size = 0.231, p = 0.003), which remained significant after false discovery rate correction (p = 0.042). The frequency of RBD was found to be correlated with tau pathology in the LC (n = 8, r = 0.752, p = 0.002). Notably, the presence of self-reported RBD symptoms mediated the relationship between LC tau pathology and PSPrs total scores (proportion-mediated = 2.09%, 95% CI 0.01%-10.00%, p = 0.044). DISCUSSION: Approximately one-fifth of patients with PSP reported RBD and exhibited more severe motor and nonmotor symptoms. The elevated 18F-florzolotau binding in the LC and its association with the presence of RBD symptoms underscore the critical role of tau pathology in disrupting sleep-regulating neural circuits. Future studies with larger sample sizes should incorporate polysomnography in patients with PSP with self-reported RBD to further elucidate this relationship.
引用
- Li XY, Tang G, Lu J, et al. Self-Reported REM Sleep Behavior Disorder in Patients With Progressive Supranuclear Palsy: Clinical and 18F-Florzolotau PET Imaging Findings. Neurology. 2025. PMID: 39951679. doi:10.1212/WNL.0000000000213376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。